{
    "organizations": [],
    "uuid": "d1db7003ceabd18b0f344a916fa59818f1e8956e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-axsome-therapeutics-says-independe/brief-axsome-therapeutics-says-independent-committee-recommends-continuation-of-depression-trial-idUSASC09XOC",
    "ord_in_thread": 0,
    "title": "Axsome Therapeutics Says Independent Committee Recommends Continuation Of Depression Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Axsome Therapeutics Inc:\n* AXSOME THERAPEUTICS ANNOUNCES POSITIVE OUTCOME OF INTERIM ANALYSIS OF STRIDE-1 PHASE 3 TRIAL OF AXS-05 IN TREATMENT RESISTANT DEPRESSION\n* AXSOME THERAPEUTICS INC - SECOND INTERIM ANALYSIS ANTICIPATED SECOND HALF OF 2018 FOR EFFICACY\n* AXSOME THERAPEUTICS INC - INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS TRIAL CONTINUATION\n* AXSOME THERAPEUTICS INC - IDMC ALSO REVIEWED AVAILABLE SAFETY INFORMATION FROM STUDY AND INDICATED AXS-05 APPEARED SAFE AND WELL-TOLERATED Source text for Eikon:\n ",
    "published": "2018-04-26T19:40:00.000+03:00",
    "crawled": "2018-04-27T16:29:12.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "axsome",
        "therapeutic",
        "inc",
        "axsome",
        "therapeutic",
        "announces",
        "positive",
        "outcome",
        "interim",
        "analysis",
        "phase",
        "trial",
        "treatment",
        "resistant",
        "depression",
        "axsome",
        "therapeutic",
        "inc",
        "second",
        "interim",
        "analysis",
        "anticipated",
        "second",
        "half",
        "efficacy",
        "axsome",
        "therapeutic",
        "inc",
        "independent",
        "data",
        "monitoring",
        "committee",
        "recommends",
        "trial",
        "continuation",
        "axsome",
        "therapeutic",
        "inc",
        "idmc",
        "also",
        "reviewed",
        "available",
        "safety",
        "information",
        "study",
        "indicated",
        "appeared",
        "safe",
        "source",
        "text",
        "eikon"
    ]
}